Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
about
Case-based study: from prediabetes to complications--opportunities for preventionAmaranth oil application for coronary heart disease and hypertensionA comprehensive review on metabolic syndromeDiuretics for heart failureFirst-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertensionTime course for blood pressure lowering of dihydropyridine calcium channel blockersHMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisFixed-dose combination therapy for the prevention of cardiovascular diseaseEffect of longer-term modest salt reduction on blood pressureFixed-dose combination therapy for the prevention of cardiovascular diseaseTime course for blood pressure lowering of angiotensin-converting-enzyme inhibitorsTime course for blood pressure lowering of dihydropyridine calcium channel blockersAntihypertensive agents for preventing diabetic kidney diseaseDiuretics for heart failureThiazide diuretics and the risk of hip fractureCalcium channel blockers versus other classes of drugs for hypertensionBlood pressure lowering efficacy of reserpine for primary hypertensionPharmacotherapy for hypertension in adults with obstructive sleep apneaDiuretics for heart failureEffect of antihypertensive drugs on mortality, morbidity and blood pressure in blacksThiazide diuretics and the risk of hip fractureAntihypertensive agents for preventing diabetic kidney diseaseInterpreting Results of Clinical Trials: A Conceptual FrameworkKnowledge translation of research findingsMechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diureticsRare independent mutations in renal salt handling genes contribute to blood pressure variationStandards of medical care in diabetes--2012Renal and brain isoforms of WNK3 have opposite effects on NCCT expressionReporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacyManidipine-delapril combination in the management of hypertensionInformative noncompliance in endpoint trialsFirst-line first? Trends in thiazide prescribing for hypertensive seniorsBeyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement - is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I)The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysisThe potential of electronic medical record systems to support quality improvement work and research in Norwegian general practiceEquivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III)Back to thiazide-diuretics for hypertension: reflections after a decade of irrational prescribingA novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on bloodCommon medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity
P2860
Q21144738-3C849D6B-B20C-4427-8E20-2F9C0F4EA956Q21245685-CF8C556E-08CC-41C9-8B82-FF82AB7A4E26Q21284500-3C90E5DA-D470-48E7-92FE-0D379724EDB4Q24185944-BE515F31-AD18-48A2-A211-2E2F3D84FC9BQ24186647-9DD73561-BB05-4B46-A585-E6D314BBC4BCQ24194238-7258574F-2E63-4CE8-B9DB-4FE512A0E238Q24194514-6A488210-9D83-4BB7-A7A3-A976D234A2A6Q24195065-447875DE-2C8E-46CA-BA89-D90B3091233DQ24197603-43DF944B-75EB-4D67-BDCB-912E3507B44CQ24198070-48CFC3FD-F9A8-476A-B689-F50076C8116EQ24201753-0F636D8F-F39C-47C5-97A2-8941DFA34E18Q24201835-3FBF8456-D8DC-45A4-A686-74E8CFC0030AQ24202090-54AB90A6-5163-48BE-A610-18E7EF017E5AQ24203661-405F5E60-662E-49E3-BB5A-F75C45DD9322Q24236268-81000403-EC64-4420-9981-F161403F028BQ24236584-A08E83D0-0075-4E8B-BA9C-03E3A24F6A60Q24239971-0C217AC9-7DD8-4232-8854-21FA3D39CFC4Q24240364-70C3AB21-9317-4EDE-B085-366C0F7F449EQ24244710-C7B0AB75-99D0-4144-840B-CB479C471406Q24245198-8D6FAD4F-797B-472F-9B8B-FD93FD40BCECQ24245500-F2D9A62C-AAAF-45E3-BC6D-5BF7628D19CDQ24245557-2920F0CF-8523-4124-BAFB-7220BF64557BQ24273399-DCFB0D61-29DE-41BF-B2ED-0C1E3C672324Q24288915-4F241212-B5F6-4052-BFFF-3E83C600CF03Q24608652-BC1DD34A-3504-4B4F-A13A-2BAC0458C258Q24627187-9CACF4EB-33A2-494B-AD20-C8182E2108F6Q24632533-4F5BB655-7FF7-45F4-8AB2-C430ED3A68FEQ24651730-B542EF61-9169-4AC3-B625-DA0370C8B6C4Q24652838-0C25E6C1-17F9-4C0D-B847-F87CE63E87D3Q24654799-4B00BF3D-AA35-4F70-BAF3-81B9066F0028Q24791524-937FDB34-9FAF-4B0A-BFF0-03DD328CAE04Q24792251-E21CAB9C-5C18-4B26-8FE8-79D61753C4FBQ24795084-533A5902-EAFA-44C2-964F-65574A2F8C78Q24801524-3BE53FB5-0528-40CD-B518-CD181586C04CQ24803099-5D3FED76-76EA-4C57-BC83-EAE94652203BQ24803870-890BA0C1-BEB9-4BFD-84BC-7DD60DA3DE20Q24805075-71449D01-CF98-4024-98E5-EE7A6E13932EQ24806038-872DA816-F6D6-425A-B443-942914B79169Q26740253-5A2E4489-4DF8-4B9B-A48C-C3A1613E4A93Q26749491-BF1B5402-994A-4BDE-850D-42D7AFAC3FF9
P2860
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Major outcomes in high-risk hy ...... nt Heart Attack Trial (ALLHAT)
@ast
Major outcomes in high-risk hy ...... nt Heart Attack Trial (ALLHAT)
@en
type
label
Major outcomes in high-risk hy ...... nt Heart Attack Trial (ALLHAT)
@ast
Major outcomes in high-risk hy ...... nt Heart Attack Trial (ALLHAT)
@en
prefLabel
Major outcomes in high-risk hy ...... nt Heart Attack Trial (ALLHAT)
@ast
Major outcomes in high-risk hy ...... nt Heart Attack Trial (ALLHAT)
@en
P3181
P356
P1476
Major outcomes in high-risk hy ...... nt Heart Attack Trial (ALLHAT)
@en
P304
P3181
P356
10.1001/JAMA.288.23.2981
P407
P577
2002-12-18T00:00:00Z